Yüklüyor......
A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia
Older patients with acute myeloid leukemia (AML) have limited treatment options and a poor prognosis, thereby warranting novel therapeutic strategies. We evaluated the efficacy of lenalidomide as front-line therapy for older AML patients. In this phase 2 study, patients 60 years of age or older with...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society of Hematology
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3318598/ https://ncbi.nlm.nih.gov/pubmed/21051557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-07-297143 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|